Individualized immunosuppression in heart transplant recipients.
Haverich
A
A
Department for Thoracic and Cardiovascular Surgery, Hannover Medical School, West Germany.
Frimpong-Boateng
K
K
Schäfers
H J
HJ
Wahlers
T
T
Fieguth
H G
HG
Herrmann
G
G
Wonigeit
K
K
Borst
H G
HG
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D008775:Methylprednisolone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone